Publication

Defining CD8(+) T cells that provide the proliferative burst after PD-1 therapy

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Sejin Im, Emory UniversityMasao Hashimoto, Emory UniversityMichael Y. Gerner, National Institute of Allergy and Infectious DiseasesJunghwa Lee, Emory UniversityHaydn Kissick, Emory UniversityMatheus C. Urger, University of Sao PauloQiang Shan, University of IowaJ. Scott Hale, Emory UniversityJudong Lee, Emory UniversityTahseen H. Nasti, Emory UniversityArlene H. Sharpe, Harvard Medical SchoolGordon J. Freeman, Harvard Medical SchoolRonald N. Germain, National Institute of Allergy and Infectious DiseasesHelder Nakaya, Emory UniversityHai-Hui Xue, University of IowaRafi Ahmed, Emory University
Language
  • English
Date
  • 2016-09-15
Publisher
  • Nature Publishing Group
Publication Version
Copyright Statement
  • © 2016 Macmillan Publishers Limited, part of Springer Nature.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0028-0836
Volume
  • 537
Issue
  • 7620
Start Page
  • 417
End Page
  • +
Grant/Funding Information
  • This work was supported by National Institutes of Health grants R01 AI30048 (R.A.), P01 AI056299 (R.A. and A.H.S.), R01 AI112579 (H.H.X.) and R01 AI121080 (H.H.X) and also by the Intramural Research Program of NIAID, NIH (R.N.G. and M.Y.G.).
  • H.T.K. is supported by funding from the Prostate Cancer Foundation and Swim Across America.
  • H.I.N. receives a CNPq research fellowship.
Abstract
  • Chronic viral infections are characterized by a state of CD8+ T-cell dysfunction that is associated with expression of the programmed cell death 1 (PD-1) inhibitory receptor. A better understanding of the mechanisms that regulate CD8+ T-cell responses during chronic infection is required to improve immunotherapies that restore function in exhausted CD8+ T cells. Here we identify a population of virus-specific CD8+ T cells that proliferate after blockade of the PD-1 inhibitory pathway in mice chronically infected with lymphocytic choriomeningitis virus (LCMV). These LCMV-specific CD8+ T cells expressed the PD-1 inhibitory receptor, but also expressed several costimulatory molecules such as ICOS and CD28. This CD8+ T-cell subset was characterized by a unique gene signature that was related to that of CD4+ T follicular helper (T FH) cells, CD8+ T cell memory precursors and haematopoietic stem cell progenitors, but that was distinct from that of CD4+ T H 1 cells and CD8+ terminal effectors. This CD8+ T-cell population was found only in lymphoid tissues and resided predominantly in the T-cell zones along with naive CD8+ T cells. These PD-1+ CD8+ T cells resembled stem cells during chronic LCMV infection, undergoing self-renewal and also differentiating into the terminally exhausted CD8+ T cells that were present in both lymphoid and non-lymphoid tissues. The proliferative burst after PD-1 blockade came almost exclusively from this CD8+ T-cell subset. Notably, the transcription factor TCF1 had a cell-intrinsic and essential role in the generation of this CD8+ T-cell subset. These findings provide a better understanding of T-cell exhaustion and have implications in the optimization of PD-1-directed immunotherapy in chronic infections and cancer.
Author Notes
  • Correspondence and requests for materials should be addressed to R.A. (Email: rahmed@emory.edu)
Keywords
Research Categories
  • Health Sciences, Immunology
  • Health Sciences, Pharmacology

Tools

Relations

In Collection:

Items